Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
An update from ACADIA Pharmaceuticals ( (ACAD) ) is now available.
Acadia Pharmaceuticals Inc. announced the involuntary termination of Brendan Teehan, its Executive Vice President and COO, effective immediately, with plans for him to assist in transitioning his duties until the end of 2024. During this period, CEO Catherine Owen Adams will take over his responsibilities, leveraging her extensive 30-year experience in the pharmaceutical sector.
For an in-depth examination of ACAD stock, go to TipRanks’ Stock Analysis page.
